Focused Wealth Management’s Quest Diagnostics DGX Stock Holding History

Focused Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-950	Closed	-$164K	–	1010
2021 Q4	$164K	Hold	950	–	–	0.03%	203
2021 Q3	$138K	Buy	+950	New	+$139K	0.02%	230
2017 Q2	–	Sell	-2,000	Closed	-$196K	–	709
2017 Q1	$196K	Hold	2,000	–	–	0.08%	142
2016 Q4	$184K	Hold	2,000	–	–	0.08%	150
2016 Q3	$169K	Hold	2,000	–	–	0.07%	157
2016 Q2	$163K	Buy	+2,000	New	+$152K	0.07%	158

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Focused Wealth Management's DGX Position: Q1 2022 in Review

Focused Wealth Management sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 950 shares — an estimated $164K sold.

Focused Wealth Management first reported a position in DGX in Q2 2016 and held it in 6 quarters. The position peaked at $196K in Q1 2017. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

Focused Wealth Management reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
Focused Wealth Management sold 950 Quest Diagnostics shares in Q1 2022, an estimated $164K.
Focused Wealth Management first reported a position in Quest Diagnostics in Q2 2016 and held it in 6 quarters.
Focused Wealth Management's Quest Diagnostics position peaked at $196K in Q1 2017.
851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Focused Wealth Management's 13F filing for Q1 2022, filed 29 Apr 2022.